{"schema_version":"1","generated_at":"2026-10-30T16:15:24.220Z","data_as_of":null,"url":"https://www.findmykol.com/kol/huda-salman","json_url":"https://www.findmykol.com/kol/huda-salman/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"huda-salman","name":"Huda Salman","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Stony Brook","state":"NY","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1790772556","orcid":"0000-0001-5305-3198","openalex":"A5112995345"},"summary":"Huda Salman is an Oncology physician. OpenAlex indexes 51 publications with 1,572 citations (h-index 15); ClinicalTrials.gov lists 3 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":51,"cited_by_count":1572,"h_index":15,"latest_activity_year":2025,"source":"works"},"trials":{"count":3,"shown":3,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT06197672","title":"Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"Huda Salman","source_url":"https://clinicaltrials.gov/study/NCT06197672","trial_url":"https://www.findmykol.com/trial/NCT06197672"},{"nct":"NCT06071624","title":"Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"Huda Salman","source_url":"https://clinicaltrials.gov/study/NCT06071624","trial_url":"https://www.findmykol.com/trial/NCT06071624"},{"nct":"NCT03829540","title":"CD4CAR for CD4+ Leukemia and Lymphoma","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"Huda Salman","source_url":"https://clinicaltrials.gov/study/NCT03829540","trial_url":"https://www.findmykol.com/trial/NCT03829540"}],"source":"trials"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Kyowa Kirin, Inc.","program_year":2021,"amount_usd":124.95,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1790772556"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1790772556","source":"payments"},"funding":{"award_count":1,"fiscal_years":{"first":2020,"last":2020},"rows_total":1,"shown":1,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R01FD006820","title":"CD4 Redirected Chimeric Antigen Receptor T Cell Therapy for CD4 Positive T Cell Neoplasms","fiscal_year":2020,"amount_usd":"260033","organization":"STATE UNIVERSITY NEW YORK STONY BROOK","source_url":"https://reporter.nih.gov/quickSearch/R01FD006820"}],"source":"grants"},"publications":{"total":49,"shown":5,"withheld":44,"matched_by":"OpenAlex author record","recent":[{"title":"Engineering resilient CAR T cells for immunosuppressive environment","year":2025,"journal":"Molecular Therapy","source_url":"https://doi.org/10.1016/j.ymthe.2025.01.035","status":"verified"},{"title":"CAR-T cell therapy for treatment of acute myeloid leukemia, advances and outcomes","year":2025,"journal":"Molecular Therapy","source_url":"https://doi.org/10.1016/j.ymthe.2025.03.052","status":"verified"},{"title":"Data from Ancestral Differences in Anticancer Treatment Efficacy and Their Underlying Genomic and Molecular Alterations","year":2025,"source_url":"https://doi.org/10.1158/2159-8290.c.7700567","status":"verified"},{"title":"Decitabine enhances tumor immunogenicity via transposable element reactivation but concurrently induces oncogene expression in Acute Myeloid Leukemia","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2025-6766","status":"verified"},{"title":"552 Feasibility and tolerability of a CD4 re-directed chimeric antigen receptor T cell therapy (CD4CAR) in hematological malignancies: Initial results from multi-institutional first-in-human (FIH) trials","year":2025,"journal":"Regular and Young Investigator Award Abstracts","source_url":"https://doi.org/10.1136/jitc-2025-sitc2025.0552","status":"verified"}],"source":"works"},"contact":{"address_1":"HSC T15 040","city":"Stony Brook","state":"NY","zip":"117948151","phone":"631-638-0910","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1790772556","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":44}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2025-03-06","provider_certified":"2025-03-06","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}